GGrantIndex
← Leaderboards

Suresh T. Chari

Mayo Clinic Coll Of Medicine, Rochester

$4,578,158
Attributed
$6,720,127
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $739.6K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,720,127 · 6

By mechanism

U01$3,544,298 · 2
R01$1,704,836 · 2
P50$1,470,993 · 1
P20$0 · 1

Top collaborators

Most similar at Mayo Clinic Coll Of Medicine, Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Diabetes Mellitus

Research focus

Diabetes MellitusMalignant Neoplasm Of PancreasDiagnosisHyperglycemiaFunctional DisorderPerformanceClinical ResearchSeriesRetrospective StudiesPathogenesisLeadMalignant NeoplasmsClinicGastroenterologistPlasmaCohortAdrenomedullinOperative Surgical ProceduresEndocrinologistIsletEpidemiologyInsulinBlood GlucoseDiabetic

Grant awards (21)

Developing methods for advancing the early detection of pancreatic ductal adenocarcinoma leveraging electronic medical records data$739,640
R01 · FY2025 · CA
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$322,976
U01 · FY2024 · DK · contact PI
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$350,540
U01 · FY2023 · DK · contact PI
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$263,224
U01 · FY2022 · DK · contact PI
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$453,329
U01 · FY2021 · DK · contact PI
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$468,829
U01 · FY2020 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$429,300
U01 · FY2018 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$429,300
U01 · FY2017 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$429,300
U01 · FY2016 · DK · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$397,500
U01 · FY2015 · DK · contact PI
Pancreatic Cancer-Associated Diabetes: Pathogenesis and Biomarkers$128,024
P50 · FY2013 · CA · contact PI
Pancreatic Cancer-Associated Diabetes: Pathogenesis and Biomarkers$294,253
P50 · FY2012 · CA · contact PI
Pancreatic Cancer-Associated Diabetes: Pathogenesis and Biomarkers$278,737
P50 · FY2011 · CA · contact PI
Pancreatic Cancer-Associated Diabetes: Pathogenesis and Biomarkers$281,065
P50 · FY2010 · CA · contact PI
Pancreatic Cancer-Associated Diabetes: Pathogenesis and Biomarkers$285,289
P50 · FY2009 · CA · contact PI
P-2: Pancreatic Cancer-Associated Diabetes: Pathogenesis and Biomarkers$203,625
P50 · FY2008 · CA · contact PI
Does Hyperglycemia Predict Pancreatic Cancer Diagnosis?$237,021
R01 · FY2006 · CA · contact PI
Does Hyperglycemia Predict Pancreatic Cancer Diagnosis?$242,725
R01 · FY2005 · CA
Does Hyperglycemia Predict Pancreatic Cancer Diagnosis?$242,725
R01 · FY2004 · CA
Does Hyperglycemia Predict Pancreatic Cancer Diagnosis?$242,725
R01 · FY2003 · CA
Does hyperglycemia predict underlying pancreatic cancer?$0
P20 · FY2003 · CA